A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
Condition:   Infections, BacterialInterventions:   Drug: GSK1322322;   Drug: EE/NE;   Drug: GSK1322322 Placebo;   Drug: EE/NE PlaceboSponsor:   GlaxoSmithKlineWithdrawn - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2013 Category: Research Source Type: clinical trials